Cell line · CVCL_0337
HuT 78
Cancer cell line, Homo sapiens. Sezary syndrome. 47 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. HuT 78. Cell lines, record CVCL_0337. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0337
On this page
Cell line
As Cellosaurus gives it.
- Name
- HuT 78
- Accession
- CVCL_0337
- RRID
- RRID:CVCL_0337
- Synonyms
- Hut 78, HUT 78, HuT-78, HUT-78, HuT78, Hut78, HUT78, NCI-H78
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 53Y
- Category
- Cancer cell line
- Diseases
- Sezary syndrome (NCIt C3366); Sezary syndrome (ORDO Orphanet_3162)
- Derived from
- Peripheral blood (in situ)
- Cell type
- T-cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers47
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| IMPDH inhibition enhances cytarabine efficacy in SAMHD1-expressing leukaemia cells via guanine nucleotide depletion. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hyperactive PLCG1 induces cell-autonomous and bystander T cell activation and drug resistance. | EMBO Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Membrane-bound IL-15 co-expression powers a potent and persistent CD70-targeted TRuC T-cell therapy. | Front Immunol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Memory T-Cell Phenotype in Cutaneous T-Cell Lymphoma Is Modified by Germline Gene Gametocyte Specific Factor 1. | Exp Dermatol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α-Cofilin-1 Axis in Cutaneous T-cell Lymphoma. | Mol Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Dual targeting of EZH2 and PD-L1 in Burkitt's lymphoma enhances immune activation and induces apoptotic pathway. | Front Immunol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1. | ACS Appl Mater Interfaces | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Small-Molecule CCR4 Antagonists in Cutaneous T-cell Lymphoma. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 47
See all 47 papersRelatives14
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | H9 | CVCL_1240 | Cell lines | |
| Derived from it | HUT 78/HIV-1SF2 | CVCL_X617 | Cell lines | |
| Derived from it | HUT 78/HIV-2D194 | CVCL_X682 | Cell lines | |
| Derived from it | HUT 78/HIV-2D205 | CVCL_X683 | Cell lines | |
| Derived from it | HUT 78/SIV-BK28 | CVCL_X611 | Cell lines | |
| Derived from it | HUT 78/SIV-BK44 | CVCL_X616 | Cell lines | |
| Derived from it | HUT 78/SIVmac251 | CVCL_X609 | Cell lines | |
| Derived from it | HuT 78/HIV-1 FRE-3 clone B4A | CVCL_D3XT | Cell lines | |
| Derived from it | HuT 78/HIV-1 FRE-3 clone C9A | CVCL_D3XU | Cell lines | |
| Derived from it | HuT 78/HIV-1 FRE-3 clone D5A | CVCL_D3XV | Cell lines |
1 to 10 of 14
See all 14 relativesCell banks13
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRM-TIB-161 | ATCC | |
| ATCC | TIB-161 | ATCC | |
| BCRC | 60522 | BCRC | |
| BCRJ | 0370 | BCRJ | |
| BEI_Resources | ARP-89 | BEI_Resources | |
| CCTCC | GDC0307 | Cellosaurus | |
| CLS | 300338 | CLS | |
| ECACC | 88041901 | ECACC | |
| Hysigen | TCH-C218 | Hysigen | |
| KCLB | 90078 | KCLB |
1 to 10 of 13
See all 13 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0337
GET https://conductscience.org/api/cell-lines/v1/CVCL_0337/papers?page=2